Ospedale San Gerardo

Futó vizsgálatok

• Toboroz

  heaRtInsiGHT Alert guIDE: RightAIDE Application of the HeartInsight Acute Heart Failure Predictor in Routine Clinical Practice: Organizational Models and Workflow.

  NCT07281859· Forrás

• Toboroz

  Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

  NCT06516406· Forrás

• Fut, nem toboroz

  Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

  NCT04476199· 2. fázis· Forrás

• Toboroz

  Protocol ITANET - Registry

  NCT04282083· Forrás

• Fut, nem toboroz

  Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

  NCT02922036· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Hasnyálmirigyrák1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Szívelégtelenség1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

  NCT06525675· Forrás

• Lezárult

  Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer

  NCT05173103· Forrás

• Lezárult

  Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies

  NCT04400981· Forrás

• Lezárult

  ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL

  NCT04603183· 2. fázis· Forrás

• Lezárult

  Follow-up in Early and Locally Advanced Breast Cancer Patients

  NCT03859453· Forrás

• Lezárult

  A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

  NCT04148911· 3. fázis· Forrás

• Leállították

  Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)

  NCT03891576· 2. fázis· Forrás

• Lezárult

  Clinical and Laboratory Characteristics of Polycythemia Vera

  NCT06134102· Forrás

• Lezárult

  Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)

  NCT03587064· Forrás

• Lezárult

  Atezolizumab Trial in Endometrial Cancer - AtTEnd

  NCT03603184· 3. fázis· Forrás

• Lezárult

  Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

  NCT03556839· 3. fázis· Forrás

• Lezárult

  A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

  NCT03371017· 3. fázis· Forrás